Search - tctmd.com

Displaying 241 - 260 of 9101

Sort: Relevancy | Date

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

Presenter: NULL

October 30, 2024

Presentation TCT 2024

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

Presenter: Aniket Venkatesh

October 30, 2024

Presentation TCT 2024

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

Presenter: Victor Alfonso Jimv©nez Dv?az

October 30, 2024

Presentation TCT 2024

TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients

Presenter: Safwan Kassas

October 30, 2024

Presentation TCT 2024

When and How Would I Use Septal Ablation to prevent or treat LVOT Obstruction?

Presenter: Paul Mahoney

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Presenter: Daniel Mitchell

October 30, 2024

Presentation TCT 2024

TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress

Presenter: Rob Eerdekens

October 30, 2024

Presentation TCT 2024

TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis

Presenter: Rob Eerdekens

October 30, 2024

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 1592: Management of Post-TAVR Severe PVL: A TAV-in-TAV Case

Presenter: Chloe Kharsa

October 30, 2024

Presentation TCT 2024

TCT 1590: Customized Cardiac Care: Percutaneous Valve-in-MAC After Alcohol Septal Ablation

Presenter: Pedro Carrilho Ferreira

October 30, 2024

Presentation TCT 2024

TCT 1587: Novel Case of Percutaneous Closure of Decommissioned HVAD due to Severe Outflow Tract to LV Regurgitation

Presenter: Cesar Soria

October 30, 2024

Advertisement

A Closer Look at the ACURATE IDE Study

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients

When and How Would I Use Septal Ablation to prevent or treat LVOT Obstruction?

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress

TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

TCT 1592: Management of Post-TAVR Severe PVL: A TAV-in-TAV Case

TCT 1590: Customized Cardiac Care: Percutaneous Valve-in-MAC After Alcohol Septal Ablation

TCT 1587: Novel Case of Percutaneous Closure of Decommissioned HVAD due to Severe Outflow Tract to LV Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content